SCHEMBL6773554

SCHEMBL6773554

O=C(O)C(CNS(=O)(=O)c1cccc(-c2ccc(CNCCc3c[nH]cn3)cc2)c1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.38
ITGB3 P05106 3/20 0.37
ITGAV P06756 3/20 0.37
LMNA P02545 3/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CASP3 P42574 4/20 0.36
NMT1 P30419 2/20 0.36
HDAC1 Q13547 2/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CG P48736 1/20 0.36
BRD4 O60885 1/20 0.35
SLC16A3 O15427 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
NAMPT P43490 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6180441 0.83 ITGB3 (0.56) ITGB3ITGAVALDH1A1
SCHEMBL6773547 0.83 PFKFB3 (0.40) ITGB3ITGAVNMT1NAMPT
SCHEMBL6773550 0.78 FFAR1 (0.48) ITGB3ITGAVSMN1; SMN2NMT1HDAC1
SCHEMBL3772416 0.70 HDAC1 (0.72) HDAC1
SCHEMBL4605920 0.70 GAA (0.53) ALDH1A1MEN1KMT2A
SCHEMBL28404275 0.68 GBA1 (0.61) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL3802084 0.68 HDAC1 (0.46) HDAC1
SCHEMBL14597960 0.67 TDP1 (0.54) LMNAALDH1A1SMN1; SMN2
SCHEMBL4637957 0.67 SFRP1 (0.47) ALDH1A1KMT2A
SCHEMBL14290772 0.65 CTSK (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677360-B2 TREATMENT AND PROPHYLAXIS OF CANCER, ARTERIOSCLEROSIS, RESTENOSIS, OSTEOPOROSIS AND EYE DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2004-01-13 US disclosed